Lisa Bishop, DO | |
5409 Avenue O, Fort Madison, IA 52627-9601 | |
(319) 376-2134 | |
(319) 376-2188 |
Full Name | Lisa Bishop |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 11 Years |
Location | 5409 Avenue O, Fort Madison, Iowa |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972943439 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | R-9767 (Iowa) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Grinnell Regional Medical Center | Grinnell, IA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Grinnell Regional Medical Center | 0446153662 | 53 |
News Archive
Parents, siblings and children of people with celiac disease are at high risk of also having the disease, according to a Mayo Clinic study. This study calls for screening of all first-degree relatives of patients - not just those who show symptoms.
BioPhotas, Inc. today announced the launch of the Celluma ELITE for sale to the Aesthetic Physician Market. The LED therapy device is stand-mounted and able to be precisely positioned over an area of treatment via an articulating arm and a patented shape-taking light panel.
Even as the COVID-19 pandemic spreads in different parts of the world, scientists are still attempting to define the characteristic signs and symptoms that are useful in diagnosing the disease. This is essential knowledge to help contain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Especially when it comes to diagnosing symptomatic or mild cases of COVID-19, such research could hold the key to identifying more people and preventing viral spread.
The American Association of Clinical Endocrinologists (AACE) today has approved the use of A1c as an additional diagnostic criterion for type 2 diabetes. An A1c of 6.5 or greater is now considered an alternate criterion for the diagnosis of type 2 diabetes.
› Verified 9 days ago
Entity Name | Grinnell Regional Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669420501 PECOS PAC ID: 0446153662 Enrollment ID: O20040127001219 |
News Archive
Parents, siblings and children of people with celiac disease are at high risk of also having the disease, according to a Mayo Clinic study. This study calls for screening of all first-degree relatives of patients - not just those who show symptoms.
BioPhotas, Inc. today announced the launch of the Celluma ELITE for sale to the Aesthetic Physician Market. The LED therapy device is stand-mounted and able to be precisely positioned over an area of treatment via an articulating arm and a patented shape-taking light panel.
Even as the COVID-19 pandemic spreads in different parts of the world, scientists are still attempting to define the characteristic signs and symptoms that are useful in diagnosing the disease. This is essential knowledge to help contain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Especially when it comes to diagnosing symptomatic or mild cases of COVID-19, such research could hold the key to identifying more people and preventing viral spread.
The American Association of Clinical Endocrinologists (AACE) today has approved the use of A1c as an additional diagnostic criterion for type 2 diabetes. An A1c of 6.5 or greater is now considered an alternate criterion for the diagnosis of type 2 diabetes.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Lisa Bishop, DO 5409 Avenue O, Fort Madison, IA 52627-9601 Ph: (319) 376-2134 | Lisa Bishop, DO 5409 Avenue O, Fort Madison, IA 52627-9601 Ph: (319) 376-2134 |
News Archive
Parents, siblings and children of people with celiac disease are at high risk of also having the disease, according to a Mayo Clinic study. This study calls for screening of all first-degree relatives of patients - not just those who show symptoms.
BioPhotas, Inc. today announced the launch of the Celluma ELITE for sale to the Aesthetic Physician Market. The LED therapy device is stand-mounted and able to be precisely positioned over an area of treatment via an articulating arm and a patented shape-taking light panel.
Even as the COVID-19 pandemic spreads in different parts of the world, scientists are still attempting to define the characteristic signs and symptoms that are useful in diagnosing the disease. This is essential knowledge to help contain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Especially when it comes to diagnosing symptomatic or mild cases of COVID-19, such research could hold the key to identifying more people and preventing viral spread.
The American Association of Clinical Endocrinologists (AACE) today has approved the use of A1c as an additional diagnostic criterion for type 2 diabetes. An A1c of 6.5 or greater is now considered an alternate criterion for the diagnosis of type 2 diabetes.
› Verified 9 days ago
Artemio Capili Santiago, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5409 Ave O, Suite 107, Fort Madison, IA 52627 Phone: 319-372-7270 Fax: 319-372-7279 | |
Dr. Pauline Mungai, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5409 Avenue O, Fort Madison, IA 52627 Phone: 319-376-2134 | |
Roseller Libarnes, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5409 Avenue O, Fort Madison, IA 52627 Phone: 319-376-2134 Fax: 319-376-2188 | |
Dr. Victoria Kogan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5409 Avenue O, Fort Madison, IA 52627 Phone: 319-376-2134 Fax: 319-376-2188 |